Top-News
Biotechnologie USA

Acorda Therapeutics News

Aktie
WKN:  A3EJA8 ISIN:  US00484M7002 US-Symbol:  ACORQ
0,51 $
-0,14 $
-21,54%
16.05.24 15:30:05
Handeln Depot/Watchlist
Aktienanzahl *
1,22 Mio.
Marktkapitalisierung *
726,78 Tsd. €
Streubesitz
-
Index-Zugehörigkeit
Nasdaq Composite Index
IR-Website
zur Website
*Stand: 05.06.2023

Acorda Therapeutics News

17.10.22 - PR Newswire
Thinking about buying stock in Federated National, Acorda Therapeutics, Nio, Avenue Therapeutics, or Visa?
Thinking about buying stock in Federated National, Acorda Therapeutics, Nio, Avenue Therapeutics, or Visa? PR Newswire
10.10.22 - PR Newswire
Thinking about buying stock in Exela Technologies, Acorda Therapeutics, NovaBay Pharmaceuticals, Meta Materials, or Faraday Future Intelligent Electric?
Thinking about buying stock in Exela Technologies, Acorda Therapeutics, NovaBay Pharmaceuticals, Meta Materials, or Faraday Future Intelligent Electric? PR Newswire
23.07.21 - PR Newswire
Thinking about buying stock in Acorda Therapeutics, Ocular Therapeutix, Ocugen, Aerpio Pharmaceuticals, or Anavex Life Sciences?
Thinking about buying stock in Acorda Therapeutics, Ocular Therapeutix, Ocugen, Aerpio Pharmaceuticals, or Anavex Life Sciences? PR Newswire
17.06.21 - PR Newswire
Thinking about buying stock in Clearside Biomedical, Acorda Therapeutics, Orphazyme, Nano-X Imaging, or Satsuma Pharmaceuticals?
Thinking about buying stock in Clearside Biomedical, Acorda Therapeutics, Orphazyme, Nano-X Imaging, or Satsuma Pharmaceuticals? PR Newswire
20.10.20 - PR Newswire
Thinking about buying stock in Aptinyx, Acorda Therapeutics, T-Mobile, Best Buy, or Advanced Micro Devices?
Thinking about buying stock in Aptinyx, Acorda Therapeutics, T-Mobile, Best Buy, or Advanced Micro Devices? PR Newswire
06.05.20 - PR Newswire
DexCom & Domino's Pizza Set to Join S&P 500; Salesforce.com to Join S&P 100; STORE Capital to Join S&P MidCap 400; Capri Holdings to Join S&P SmallCap 600
DexCom & Domino's Pizza Set to Join S&P 500; Salesforce.com to Join S&P 100; STORE Capital to Join S&P MidCap 400; Capri Holdings to Join S&P SmallCap 600 PR Newswire
23.05.19 - PR Newswire
Wedbush Securities Senior Vice President of Equity Research Laura Chico, Ph.D. Initiates Coverage on Six Stocks in the Healthcare and BioTech Space - ACER, ACOR, ALNX, BIIB, DOVA and SAGE
Wedbush Securities Senior Vice President of Equity Research Laura Chico, Ph.D. Initiates Coverage on Six Stocks in the Healthcare and BioTech Space - ACER, ACOR, ALNX, BIIB, ...
22.12.17 - PR Newswire
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Acorda Therapeutics, Inc. - ACOR
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Acorda Therapeutics, Inc. - ACOR PR Newswire
16.12.17 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acorda Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ACOR
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acorda Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline ...
14.12.17 - PR Newswire
Shareholder Class Action Filed Against Acorda Therapeutics, Inc. - ACOR
Shareholder Class Action Filed Against Acorda Therapeutics, Inc. - ACOR PR Newswire
12.12.17 - PR Newswire
ACORDA THERAPEUTICS DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Acorda Therapeutics, Inc. To Contact The Firm
ACORDA THERAPEUTICS DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Acorda Therapeutics, Inc. To Contact The ...
04.12.17 - PR Newswire
ACT NOW: Monteverde & Associates PC Announces An Investigation of Acorda Therapeutics, Inc. - ACOR
ACT NOW: Monteverde & Associates PC Announces An Investigation of Acorda Therapeutics, Inc. - ACOR PR Newswire
28.11.17 - PR Newswire
Johnson Fistel, Announces Investigations of INC Research Holdings, Inc., Acorda Therapeutics, Inc., and Shopify Inc.; Investors Encouraged to Contact Firm
Johnson Fistel, Announces Investigations of INC Research Holdings, Inc., Acorda Therapeutics, Inc., and Shopify Inc.; Investors Encouraged to Contact Firm PR Newswire
20.11.17 - PR Newswire
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Acorda Therapeutics, Inc. (ACOR) and Lead Plaintiff Deadline: January 17, 2018
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Acorda Therapeutics, Inc. (ACOR) and Lead Plaintiff Deadline: January 17, ...
16.11.17 - PR Newswire
ACORDA THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In Acorda Therapeutics, Inc. To Contact The Firm
ACORDA THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In Acorda Therapeutics, Inc. To Contact The Firm PR ...
15.11.17 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acorda Therapeutics, Inc. - ACOR
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acorda Therapeutics, Inc. - ACOR PR Newswire
15.11.17 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acorda Therapeutics, Inc. - ACOR
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acorda Therapeutics, Inc. - ACOR PR Newswire
15.11.17 - PR Newswire
Kaplan Fox Announces Investigation of Acorda Therapeutics, Inc.
Kaplan Fox Announces Investigation of Acorda Therapeutics, Inc. PR Newswire
15.11.17 - PR Newswire
INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Acorda Therapeutics, Inc. (ACOR)
INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Acorda Therapeutics, Inc. (ACOR) PR Newswire
15.11.17 - PR Newswire
Thinking about buying Acorda Therapeutics, JA Solar, Ultragenyx Pharmaceuticals, Square Inc. or Target?
Thinking about buying Acorda Therapeutics, JA Solar, Ultragenyx Pharmaceuticals, Square Inc. or Target? PR Newswire

Newssuche

Videos

newspaper
14.05.24 -16,04%
Technical Trading: DAX dienstags Long
DAX Long Typ: Turbo Open End WKN: NG8K9X Hebel: 26 Laufzeit: OpenEnd Einstieg: Market ... Mehr »